AQP4 and myeloid sarcoma: <h4>Background and objective</h4>Differentiating neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS) is clinically difficult, especially when patients are seronegative for anti-aquaporin-4 immunoglobulin G (AQP4-IgG).